| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 11, 2024 | Sale | $78.26 | 2,801 | 219,206 | 60,070 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 12, 2024 | Sale | $74.44 | 1,146 | 85,308 | 61,174 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Feb 20, 2024 | Sale | $79.67 | 1,913 | 152,409 | 57,371 | Feb 21, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 13, 2023 | Option Exercise | $43.22 | 2,305 | 99,622 | 54,844 | Mar 14, 2023, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Feb 21, 2023 | Option Exercise | $48.26 | 1,950 | 94,107 | 52,066 | Feb 22, 2023, 05:35 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 05, 2022 | Option Exercise | $52.26 | 3,234 | 169,009 | 50,191 | Dec 06, 2022, 05:47 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 11, 2022 | Option Exercise | $62.56 | 1,321 | 82,642 | 45,218 | Mar 14, 2022, 06:01 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 14, 2022 | Option Exercise | $61.08 | 1,039 | 63,462 | 46,429 | Mar 14, 2022, 06:01 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 06, 2021 | Option Exercise | $69.17 | 6,303 | 435,978 | 43,542 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 02, 2021 | Option Exercise | $13.62 | 7,342 | 99,998 | 36,512 | Dec 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Sep 13, 2021 | Option Exercise | $117.86 | 4,741 | 558,774 | 29,170 | Sep 14, 2021, 09:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 10, 2021 | Option Exercise | $124.15 | 1,353 | 167,975 | 23,911 | Mar 12, 2021, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Jan 19, 2021 | Option Exercise | $51.49 | 27,500 | 1,415,975 | 49,931 | Jan 20, 2021, 06:05 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Jan 19, 2021 | Sale | $204.94 | 27,500 | 5,635,944 | 43,146 | Jan 20, 2021, 06:05 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 09, 2020 | Option Exercise | $13.62 | 22,026 | 299,994 | 22,415 | Dec 10, 2020, 04:35 PM |
Menu